Use of Imatinib to Convert Triple Negative Breast Cancer Into ER-positive Breast Cancer (I-CONIC)

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Use of Imatinib to Convert Triple Negative Breast Cancer Into ER-positive Breast Cancer (I-CONIC)	Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder, triple-negative breast carcinoma	Recruiting	Not applicable	2025-07-09		NCT05722795

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Lund University	133
Sahlgrenska University Hospital	158
Vastra Gotaland Region	163

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Barbro Linderholm	Gothenburg	Sweden	1

Clinical trials